“Biochemical, Hematological and Immunological Indices Among MDR-TB on Second Line Anti TB and MDR-TB-HIV Co-Infected Patients on Second Line Anti TB and ARV Drugs for a Six -Month Treatment” (2020) Tanzania Medical Journal, 31(3), pp. 1–14. doi:10.4314/tmj.v31i3.359.